By Sheeba M. | May 18, 2026
Edibles Are Now 42% of MSO Revenue—And Wall Street Isn’t Watching
The narrative around cannabis stocks is stuck in 2024. Analysts talk about “flower saturation” and “race to the bottom on pricing.” That story is dead.
What’s actually happening: Edibles consumption is outpacing flower. Cannabis-infused products—gummies, beverages, chocolates, inhalables—now represent 42% of cannabis retail revenue. And critically: these categories have 3-5x higher margins than commodity flower.
This is the margin story Wall Street missed:
- Curaleaf‘s proprietary edibles line now does $80M+ annually—at 65% gross margins
- Cresco Labs owns three premium edibles brands, combined $120M+ revenue run-rate
- Green Thumb reports branded products (majority edibles) at 58% gross margins vs. 42% for wholesale flower
Here’s the kicker: As edibles scale nationally (thanks to federal rescheduling easing distribution), the revenue mix keeps shifting higher-margin. By end of 2026, edibles could be 50%+ of revenue for mature operators. That’s a 400-500 bps margin lift for the whole sector.
Cannabis MSOs are accidentally becoming consumer packaged goods companies. That’s not reflected in 8x EV/EBITDA multiples. It’s reflected in 12-14x multiples. The gap is your edge.
The tactical play: Verano and Ascend Wellness are lagging on edibles penetration. When they catch up, their multiples re-rate hard. Trulieve is already ahead—which is one reason its debt is refinancing at better rates.
Sources
- Grand View Research — Cannabis edibles market analysis
- Curaleaf Investor Relations — Q1 2026 edibles revenue disclosure
- Cresco Labs Investor Relations — Branded products margin data
Track cannabis stocks with the Weedstock Real-Time Tracker